Jetema Co Stock Current Liabilities

216080 Stock  KRW 18,040  130.00  0.73%   
JETEMA Co fundamentals help investors to digest information that contributes to JETEMA's financial success or failures. It also enables traders to predict the movement of JETEMA Stock. The fundamental analysis module provides a way to measure JETEMA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to JETEMA stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

JETEMA Co Company Current Liabilities Analysis

JETEMA's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Current Liabilities

 = 

Payables

+

Accrued Debt

More About Current Liabilities | All Equity Analysis
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition

In accordance with the recently published financial statements, JETEMA Co has a Current Liabilities of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Pharmaceuticals (which currently averages 0.0) industry. The current liabilities for all Republic of Korea stocks is 100.0% higher than that of the company.

JETEMA Current Liabilities Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses JETEMA's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of JETEMA could also be used in its relative valuation, which is a method of valuing JETEMA by comparing valuation metrics of similar companies.
JETEMA is currently under evaluation in current liabilities category among its peers.

JETEMA Fundamentals

About JETEMA Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze JETEMA Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JETEMA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JETEMA Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with JETEMA

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if JETEMA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in JETEMA will appreciate offsetting losses from the drop in the long position's value.

Moving against JETEMA Stock

  0.79047920 HLB PharmaceuticalPairCorr
  0.78030350 Dragonfly GF SplitPairCorr
  0.59023910 Daihan PharmaceuticalPairCorr
  0.55353190 HurumPairCorr
  0.45254120 XavisPairCorr
The ability to find closely correlated positions to JETEMA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace JETEMA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back JETEMA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling JETEMA Co to buy it.
The correlation of JETEMA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as JETEMA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if JETEMA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for JETEMA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in JETEMA Stock

JETEMA financial ratios help investors to determine whether JETEMA Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in JETEMA with respect to the benefits of owning JETEMA security.